Fair 2°
Tag:

Vaccine Research

Business
COVID-19: Pfizer Launches Clinical Trial For Vaccine Targeting Omicron Variant COVID-19: Pfizer Launches Clinical Trial For Vaccine Targeting Omicron Variant
Covid-19: Pfizer Launches Clinical Trial For Vaccine Targeting Omicron Variant New York-based Pfizer and its European partner BioNTech have launched a clinical study to evaluate a COVID-19 vaccine that specifically targets the Omicron variant. The study will evaluate the safety and efficacy of an Omicron-based vaccine among healthy adults ages 18 through 55, Pfizer announced on Tuesday, Jan. 25. According to a recent update from the Centers for Disease Control and Prevention (CDC), the Omicron variant is estimated to have accounted for 99.5 percent of circulating variants of COVID-19 in the United States between Sunday, Jan. 9, and Saturday, Jan. 15. Pfizer said up t…

SHARE

by Nicole Valinote
News
COVID-19: New Studies Shed Light On Moderna Vaccine's Effectiveness Against Variants COVID-19: New Studies Shed Light On Moderna Vaccine's Effectiveness Against Variants
Covid-19: New Studies Shed Light On Moderna Vaccine's Effectiveness Against Variants Researchers have found that the Moderna COVID-19 vaccine has proven effective in fighting off more contagious variants of the virus. A pair of new studies found that the Moderna vaccine, which is one of three approved by the FDA for administration in the U.S., is effective against the California variant that has recently been rapidly spreading, with protection lasting for at least six months. In one study, researchers from Duke University found that antibodies generated by the Moderna dose had approximately two times less neutralizing power against the California strain. While it showed a …

SHARE

by Zak Failla